PNC Financial Services Group
REGN icon

PNC Financial Services Group’s Regeneron Pharmaceuticals REGN Stock Holding History

PNC Financial Services Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Sell
16,662
-1,564
-9% -$1.06M 0.01% 571
2026
Q1 		$14.1M Buy
18,226
+866
+5% +$663K 0.01% 485
2025
Q4 		$13.4M Buy
17,360
+44
+0.3% +$29.9K 0.01% 495
2025
Q3 		$9.74M Buy
17,316
+2,601
+18% +$1.47M 0.01% 555
2025
Q2 		$7.73M Sell
14,715
-1,247
-8% -$696K 0.01% 583
2025
Q1 		$10.1M Sell
15,962
-755
-5% -$519K 0.01% 520
2024
Q4 		$11.9M Sell
16,717
-1,608
-9% -$1.35M 0.01% 484
2024
Q3 		$19.3M Buy
18,325
+153
+0.8% +$170K 0.01% 403
2024
Q2 		$19.1M Sell
18,172
-496
-3% -$481K 0.01% 397
2024
Q1 		$18M Buy
18,668
+467
+3% +$444K 0.01% 411
2023
Q4 		$16M Sell
18,201
-99
-0.5% -$81.5K 0.01% 416
2023
Q3 		$15.1M Sell
18,300
-476
-3% -$374K 0.01% 409
2023
Q2 		$13.5M Sell
18,776
-763
-4% -$588K 0.01% 442
2023
Q1 		$16.1M Sell
19,539
-241
-1% -$182K 0.01% 414
2022
Q4 		$14.3M Sell
19,780
-1,042
-5% -$769K 0.01% 422
2022
Q3 		$14.3M Sell
20,822
-818
-4% -$515K 0.02% 407
2022
Q2 		$12.8M Sell
21,640
-937
-4% -$609K 0.01% 435
2022
Q1 		$15.8M Sell
22,577
-785
-3% -$497K 0.01% 432
2021
Q4 		$14.8M Buy
23,362
+12,587
+117% +$7.74M 0.01% 469
2021
Q3 		$6.52M Sell
10,775
-640
-6% -$397K 0.01% 593
2021
Q2 		$6.38M Buy
11,415
+259
+2% +$131K 0.01% 598
2021
Q1 		$5.28M Sell
11,156
-1,822
-14% -$887K 0.01% 627
2020
Q4 		$6.27M Sell
12,978
-1,250
-9% -$675K 0.01% 568
2020
Q3 		$7.96M Sell
14,228
-2,082
-13% -$1.26M 0.01% 499
2020
Q2 		$10.2M Buy
16,310
+1,658
+11% +$941K 0.01% 445
2020
Q1 		$7.16M Buy
14,652
+3,494
+31% +$1.44M 0.01% 472
2019
Q4 		$4.19M Sell
11,158
-3,961
-26% -$1.33M ﹤0.01% 639
2019
Q3 		$4.19M Buy
15,119
+3,459
+30% +$1.02M ﹤0.01% 710
2019
Q2 		$3.65M Sell
11,660
-21,450
-65% -$7.14M ﹤0.01% 797
2019
Q1 		$13.6M Buy
33,110
+413
+1% +$170K 0.01% 448
2018
Q4 		$12.2M Sell
32,697
-317
-1% -$116K 0.01% 450
2018
Q3 		$13.3M Buy
33,014
+3,692
+13% +$1.41M 0.01% 477
2018
Q2 		$10.1M Buy
29,322
+541
+2% +$169K 0.01% 537
2018
Q1 		$9.91M Buy
28,781
+6,566
+30% +$2.28M 0.01% 530
2017
Q4 		$8.35M Sell
22,215
-1,688
-7% -$684K 0.01% 567
2017
Q3 		$10.7M Buy
23,903
+225
+1% +$107K 0.01% 506
2017
Q2 		$11.6M Buy
23,678
+1,136
+5% +$497K 0.01% 479
2017
Q1 		$8.73M Buy
22,542
+1,679
+8% +$622K 0.01% 530
2016
Q4 		$7.66M Sell
20,863
-1,709
-8% -$650K 0.01% 549
2016
Q3 		$9.08M Sell
22,572
-52
-0.2% -$20.9K 0.01% 522
2016
Q2 		$7.9M Sell
22,624
-983
-4% -$379K 0.01% 531
2016
Q1 		$8.51M Buy
23,607
+1,975
+9% +$814K 0.01% 519
2015
Q4 		$11.7M Sell
21,632
-8,915
-29% -$4.83M 0.01% 449
2015
Q3 		$14.2M Buy
30,547
+438
+1% +$235K 0.02% 434
2015
Q2 		$15.4M Buy
30,109
+1,425
+5% +$695K 0.02% 432
2015
Q1 		$12.9M Buy
28,684
+2,948
+11% +$1.25M 0.01% 472
2014
Q4 		$10.6M Buy
25,736
+2,074
+9% +$816K 0.01% 502
2014
Q3 		$8.53M Buy
23,662
+2,075
+10% +$695K 0.01% 536
2014
Q2 		$6.1M Buy
21,587
+3,382
+19% +$1M 0.01% 586
2014
Q1 		$5.47M Buy
18,205
+315
+2% +$97K 0.01% 584
2013
Q4 		$4.92M Sell
17,890
-1,347
-7% -$387K 0.01% 611
2013
Q3 		$6.02M Buy
19,237
+694
+4% +$183K 0.01% 548
2013
Q2 		$4.17M Buy
+18,543
New +$4.32M 0.01% 610

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

PNC Financial Services Group's REGN Position: Q2 2026 in Review

PNC Financial Services Group reduced its Regeneron Pharmaceuticals (REGN) stake by 8.6% in Q2 2026, selling an estimated $1.06M and leaving 16,662 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #571.

PNC Financial Services Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.3M in Q3 2024. 748 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • PNC Financial Services Group held 16,662 shares of Regeneron Pharmaceuticals worth $10.4M as of Q2 2026.
  • PNC Financial Services Group sold 1,564 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.06M.
  • Regeneron Pharmaceuticals made up 0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #571 holding.
  • PNC Financial Services Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Regeneron Pharmaceuticals position peaked at $19.3M in Q3 2024.
  • 748 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.